chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt vaccinated with MMR experienced severe teething & nasal congestion. High fever had a seizure lasted approx 30 to 60 min. Seen in ER w/temp of 104.4 rt sided weakness consistent w/Todds paralysis. See WORM for more details.
This case was reported by a pharmacist and described the occurrence of injection site hives in a 35-year-old female subject who was vaccinated with FLULAVAL (GlaxoSmithKline). On 15 October 2013 at 10:00 the subject received a dose of FLULAVAL (.5 unknown, unknown, left arm). On 15 October 2013, 30 minutes after vaccination with FLULAVAL, the subject experienced injection site hives, itching to hips and hive. About 30 minutes after the FLULAVAL vaccine, the subject started "getting hives around the injection site" and "itching on her hips" with hives there as well. The subject was instructed by the pharmacist to take BENADRYL and seek medical attention if they worsened. The subject reported to the pharmacist that when she woke up the next morning [16 October 2013], she was "covered in hives". The subject saw her healthcare provider, but the pharmacist did not know what treatment the subject received. The vaccine was administered at a local dental office as part of a flu clinic. According to the pharmacist, it had been a "very long time" since the subject's last flu shot, but she did not have a reaction with the flu shot in the past. The pharmacist considered the events were clinically significant (or requiring intervention). The subject was treated with BENADRYL. At the time of reporting the events were worse. The pharmacist considered the events were probably related to vaccination with FLULAVAL.
one dose of VARIVAX was improperly stored on 12/28/2021 and administered to one patient on the same day; This spontaneous report was received from a physician concerning a patient of unknown age and gender. Information regarding the patient's concomitant therapies, current conditions, medical history and historical drug was not provided.   On 28-DEC-2021, the patient started therapy with varicella virus vaccine live (Oka/Merck) (VARIVAX) lot number T032322 expiration date 22-SEP-2022 (Dosage regimen and route of administration were not provided) prophylaxis.  The improperly stored dose of the suspect vaccine experienced a temperature excursion of 6.4 degree fahrenheit (°F) for 2 hours 30 minutes on 28-DEC-2021; no previous temperature excursions were reported.; Sender's Comments:  US-009507513-2201USA000559:
Cytokine storm; fever; short of breath; ground-glass opacities with the lung; This is a spontaneous report from a contactable consumer (husband) reported for a female patient  A female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# unknown), via an unspecified route of administration on Apr2021 as single dose for covid-19 immunisation. First dose was administered in an unknown date in 2021. The patient medical history was not reported. The patient's concomitant medications were not reported. A month later, in the end of May, she started to have fever, and it lasted over 5 weeks. On the week five, she was admitted to withheld and after ruling out all infectious reasons, she was diagnosed as cytokine storm (onset in an unspecified date in 2021) related with the Covid vaccine. Her Covid19 antibody is >2500. She has been taking steroids (prednisone 50mg) since then, all metrics and cytokine storm are getting better. But in week nine, all of a sudden, the fever came back at 40.8 degree, and had short of breath symptom. She had to go ER at 2am on Sat and was transferred to ICU then, the doctor said many metrics and symptoms were very similar to Covid19 patients, but her covid19 test result was still negative. The symptoms she had including short of breath, fever, ground-glass opacities with the lung, and some metrics including WBC:35.56, Ferritin: 35114, CRP: 173.0, Lactic dehydrogenase: 2871, Ddimer>1000. Reporter said his wife is suffering from Cytokine storm which is very likely causing by the Covid19 vaccine, and she is having symptoms very similar to Covid19 patients. Her current doctors do not have much knowledge about the vaccine, so they cannot provide good solution for this issue.  The outcome of Cytokine storm was recovering. The outcome of fever was not recovered. The outcome of short of breath and ground-glass opacities with the lung was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Patient called and reported a rash a couple of hours after receiving the Pfizer COVID vaccination.  Patient had previously stated that she had no allergies.  She also reported to not have a Primary Care Provider.  Recommended to patient to take some Benadryl and if the reaction progressed/worsened to go to the ER.
Swollen Lymph Nodes, 16 hours after injection, Rest, Fluids, Benedryl 10 mg - Symptom persists Itchy Throat, 8  hours after injection, Rest, Fluids, Benedryl 10 mg - Symptom persists Low-Grade Fever, 30  hours after injection, One dose of Tylenol - Symptom persists Malaise, 8  hours after injection, Rest and Fluids - Symptom persists
This spontaneous report as received from a physician via company representative, and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 12-MAR-2014, the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23 "10 Single dose 0.5mLVIs 10SDV" and lot number J009689 with expiration date of 29-JAN-2015 (route of administration was unknown), which was stored at 34 Fahrenheit (F) Degrees (1.111111111 Celsius) for a total of 144 hours. The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effect were reported and nor product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
I now have vertigo. I?ve had 5 episodes since my vaccination. I?ve never had vertigo prior to this.
This patient was brought into urgent care by their parents for their pfizer covid booster. The patient had already received their monovalent booster and was eligible for  the bivalent booster. The bivalent booster had not yet been received in clinic yet and this patient was given another dose of the monovalent vaccine in error.
warm at the injection site; hard at the injection site; 3.5 inches diameter bright red flush at the injection site; swollen at the inejction site; redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE ERYTHEMA (3.5 inches diameter bright red flush at the injection site), VACCINATION SITE WARMTH (warm at the injection site), VACCINATION SITE SWELLING (swollen at the inejction site) and VACCINATION SITE INDURATION (hard at the injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concomitant products included ABALOPARATIDE (TYMLOS) and ACETYLSALICYLIC ACID (CARTIA [ACETYLSALICYLIC ACID]) for an unknown indication.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness at the injection site). On 31-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (3.5 inches diameter bright red flush at the injection site), VACCINATION SITE WARMTH (warm at the injection site), VACCINATION SITE SWELLING (swollen at the inejction site) and VACCINATION SITE INDURATION (hard at the injection site). The patient was treated with PARACETAMOL (TYLENOL) on 24-Jan-2021 for Vaccination site erythema, at a dose of UNK dosage form and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 31-Jan-2021 for Vaccination site erythema, at a dose of UNK dosage form. On 26-Jan-2021, VACCINATION SITE ERYTHEMA (redness at the injection site) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (3.5 inches diameter bright red flush at the injection site), VACCINATION SITE WARMTH (warm at the injection site), VACCINATION SITE SWELLING (swollen at the inejction site) and VACCINATION SITE INDURATION (hard at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Eight hours after the shot patient experienced redness at the injection site (lasted 2 days). On 31-Jan-2021 a 3.5 inches diameter bright red flush appeared again at the injection site. It was warm, swollen and hard.
A 9 month old female received her 2nd dose of Prevnar on 6/12/00 and within 4 days, became fussy and irritable. Her appetite decreased and she began pulling on her ear. The pt has a recent history of 2 previous ear infections and was treated with antibiotics.
[Moderna COVID-19 Vaccine] use for COVID-19 under Emergency Use Authorization (EUA): patient received COVID-19 Moderna vaccine. 12 minutes after injecting, patient reported lip tingling and patient was moved to an extended observation room. The patient then received diphenhydramine 25 mg capsule. Patient's blood pressure elevated at 196/120 and was then transported to ER. Patient evaluated at ER and given additional diphenhydramine 25 mg PO, prednisone 50 mg PO, famotidine 20 mg PO.
got shingrix vaccine in 2019; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in 2019).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 25-APR-2022 Reporter's Comment: The patient self-reported this case via interactive digital media. The patient got Shingrix vaccine in 2019 and asked when should he/she get it again. Additional supportive information: Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. The follow-up would not possible, as no contact, details were available.
Patients PCP ok'd patient to get the covid pfizer booster not knowing that the patient previously had moderna.  patient was given the vaccine. than the patient handed me his vaccine card and it stated moderna vaccines.  advised patient that i needed to talk to my nurse cause the cdc doesn't recommend patients getting the pfizer if they got any of the other vaccines. nurse notified. reported within in our system.  patient waited in room at least 20 min after being given the vaccine and he had no reaction no complaints.
Information has been received from a NP concerning a 29 month old white male who on 4/9/99 was vaccinated with 1st dose of MMR. On 4/9/1999, immediately, post vax, the pt experienced injection site swelling with erythema. Later that same day he experienced mild facial edema and was placed on therapy with Benadryl. The reporter noted in follow-up that the pt recovered on 4/9/99. No further information is available.
TINGLING SENSATION TO FACE AND FEET,NAUSEA;  PT REPORTS SYMPTOMS STARTED 4MINS AFTER GETTING VACCINE. BP 166/97 P73 O2SAT 95%. 11:05AM PT REPORTED SYMPTOMS HAVE SUBSIDED..PT INSTRUCTED TO FOLLOW UP WITH PCP FOR BP CHECK FOLLOW UP.
Moderna COVID-19 Vaccine EUA Low grade fever (99.9). Arm red, warm, tender Swolten at 2 1/2" x 2". Itchy. Body aches
Following vax pt exp tachycardia, elevation of BP to 150/100, palpable purpura w/assoc necrotic centers on lower extremities & arthralgia of the wrist, metacarpophalangeal joints, ankles, & lt knee; dx vasculitis;
father devel chicken pox rash on hands & feet subsequent to his 32 month old daughter who was vaccinated w/ varicella vax developing same rxn;
Low grade temp. extremity aches, night sweats, nausea x 6 days, elevated imflammatory markers.
Guideline stated that child should be given preservative free flu vaccine and pharmacy define child as anyone who is under 18 yrs, so FLUVIRIN which has preservative should not be given to the patient.  No adverse reaction per father also, had sister at Dr's office related to incidence.
On June 1, 2022, in the afternoon, I came down with a low-grade fever, a little bit of lose bowel movement, a lot of head congestion, and a deep cough. I took an at home test and tested positive for COVID-19. I waited until the next day to call my doctor office to request a prescription for Paxlvoid.  I took the Paxlovid for 5 days straight.  I also experience a Paxlovid rebound positive COVID-19 test.
Fatigue; Fever; pain; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 16Apr2021 at 12:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not take concomitant medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On an unknown date in 2021 the patient experienced fatigue, fever and pain. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fatigue, fever and pain was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
FEVER, REDNESS IN BOTH LOWER EXTREMITIES, RASH IN BODY. WAS GIVEN ACETAMINOPHEN.
skin infection; This is a spontaneous report from a contactable Pharmacist reported for a female patient. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced skin infection. The patient already got the 1st dose and would like to confirm if it's true that she cannot take antibiotics for her skin infection that she experienced after 1st dose. Patient asking if when she can take the 2nd dose. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
About 3 days after my vaccine, I started getting tinnitus, a high-pitched, cricket-like ringing in my left ear.  It's been over 24 hours and hasn't gone away.  I do also have pain in that ear, but that started the next day and may be due to my putting in earwax drops to try to loosen things up in there in case this was caused by wax.  I did get other side effects not long after the vaccine, but they are "standard" expected ones, so I don't know if you need a report for them.  I got a sore arm.  Within a few hours of the vaccine, I was "spacey" (not thinking completely clearly, thinking slower and having difficulty concentrating).  I was sleepy and lay down for about 45 minutes, but I'm not sure if I slept. I got the standard fever, chills, and muscle aches lasting about two or two and a half days after the vaccine.    A little stomach upset on and off, but I get that normally.  A little more nausea than usual, though.
Mild hives / itching over much of torso as well as upper arm and upper leg regions.  Not treatment at time of reporting (consulting with health provider).
Pt received DT on 9/24/03. On 9/25/03 and 9/26/03 had nausea, body aches, and vaccine site quite tender, red and swollen. On Sat. jaw was "stuck" but she got it open. On Sun. could only get jaw open 1 in. On Mon. was fine Tues. "locked" in the am and better after rest. No other sxs.
Heart rate was high - never got higher than 100; Blood pressure was high; My stomach started to hurt; Felt heavy pressure; A spontaneous report  was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced heart rate was high, never got higher that 100, high blood pressure, stomach started to hurt and felt heavy pressure.   The patient's medical history included seasonal allergies. The concomitant medications reported included fexofenadine hydrochloride and montelukast sodium.  On 30 Dec 2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 039K20-2A) intramuscularly for prophylaxis of COVID-19 infection.   Within 15 minutes of receiving the vaccine, the patient experienced heart rate was high, never got higher that 100, high blood pressure, stomach started to hurt and felt heavy pressure. She stated that it got intense for couple minutes and was cyclic.   The patient was taken to the emergency room (ER) for further observation. The whole episode had lasted a total of 3 hours. Upon contacting her allergist.  Action taken with mRNA-1273 in response to the events was considered unknown.   The outcome of heart rate was high, never got higher that 100, high blood pressure, stomach started to hurt and felt heavy pressure was not resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Started having chills about 6:10pm check temp and it was 100.2 and took 2 ex-strength Tylenol. about 10:30 pm started feeling hot and checked Temp and it was 101.2 took 2 more ex-strength Tylenol finally about 12am my Temp was 98.9. by 6am Temp was 97.7.   As of 3/8/21 my left arm is still sore and swollen. Under my left arm is also swollen. I think its my lymph nodes.
pt recv vax in 1994 & pt exp wheezing, edema & severe skin sensitivity;@ approx the same time it was determined that pt had an allergy to yeast;f/u info revealed that there was no clinical evidence of a yeast allergy;
ADMINISTRATION ERROR-   Pt was accidentally given the Bivalent Pediatric Pfizer vaccine instead of the Monovalent Primary dose of Pediatric Pfizer vaccine.
i recieved my vaccinations at age two and a half within two days of vaccinations i began stumbling and falling my hip was giving out and i was walking with a limp before my vaccinations i was walking normal i am 42 two years old now and walk with a cane and walking is very difficult and have severe back and hip pain and can no longer work and in the process of fighting for disability.  1/28/2010 I cam down with a limp after the vaccine and also my hip was giving out I now walk with a cane and have severe lower back pain and my walk has gotten much worse.
Developed shingles. While correlation doesn't mean causation I'm suspicious that COVID vaccine work on immune system and shingles crops up when that immune system fails to suppress the chicken pox vaccine.
Administration of expired Moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of expired Moderna vaccine) in a 60-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of expired Moderna vaccine). On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administration of expired Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  It was reported that the vaccine was stored in freezer, one of two vials were taken out and placed in fridge each day as needed.  No treatment given to the patient.
balance problems; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An 82-year-old male patient received BNT162b2 (BNT162B2), in 2021 as dose number unkn0wn, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BALANCE DISORDER (non-serious) with onset Mar2021, outcome "not recovered", described as "balance problems". The event "balance problems" required physician office visit.  Additional information: Serious reported as No. Patient had his Pfizer Covid19 vaccines I wouldn't have taken it if I knew the shot was like this  I took it in Jan or Feb later clarifying of last year meaning 2021. He went on to say, in Mar... like a week or two after I took the shots... my knees gave way on me then I started to have balance problems and all sort of health issues that I never had before. I'm 82 years old and up until I took that shot not many people could outrun me, or out-do, or out work there or do anything better than I could. reiterating that he has all these other problems" in addition to the balance problems but did not elaborate. Adding I'm going to a couple of doctors now, to try and see what I can do to resolve that.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Fatigue, chills, fevers, myalgias, malaise, headache, stuffy nose started about eight hours after vaccination.